Delivery of multipotent adult progenitor cells via a functionalized plasma polymerized surface accelerates healing of murine diabetic wounds

Introduction: Stem cell therapies have been investigated as potential treatment modalities for chronic wounds however there has been limited success to date. Multipotent Adult Progenitor Cells (MAPCs©) have been identified as having potential as an allogenic stem cell product due to their high population doubling number and their characteristic dampening of T-cell proliferation. This helps to prevent autoimmunity and graft/cell rejection. Methods: We have developed a dressing, consisting of medical grade silicone coated with a heptylamine plasma polymer, which supports the growth and transfer of MAPCs to skin. To determine if the dressing can deliver functional stem cells into diabetic wounds, they were loaded with MAPCs and then placed over excisional wounds in both normal and diabetic mice. Results and discussion: Accelerated healing was observed in both the normal and diabetic wounds with wound gape being significantly smaller at day 3 when compared to controls. Wound analysis showed that treatment with the MAPC dressings dampened the inflammatory response with reduced numbers of neutrophils and macrophages observed. Additionally, an increase in pro-angiogenic VEGF and CD31 positive endothelial cells was observed indicating improved new blood vessel formation. The MAPC dressings had no effect on fibrosis with collagen I and III being equally affected in both control and treated wounds. Overall, the functionalized MAPC dressings improve healing responses particularly in diabetic mice with impaired healing responses and therefore, show potential for development as an advanced therapeutic approach for the treatment of chronic diabetic wounds.

[1]  J. Ankrum,et al.  Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products , 2022, Stem cells translational medicine.

[2]  K. English,et al.  IFN‐γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease , 2021, Stem cells translational medicine.

[3]  Giles T S Kirby,et al.  Plasma-polymerized pericyte patches improve healing of murine wounds through increased angiogenesis and reduced inflammation , 2021, Regenerative biomaterials.

[4]  A. Cowin,et al.  Mesenchymal Stem Cell Secretome as an Emerging Cell-Free Alternative for Improving Wound Repair , 2020, International journal of molecular sciences.

[5]  A. Luttun,et al.  Multipotent adult progenitor cells grown under xenobiotic-free conditions support vascularization during wound healing , 2020, Stem cell research & therapy.

[6]  Louise E. Smith,et al.  Human multipotent adult progenitor cell-conditioned medium improves wound healing through modulating inflammation and angiogenesis in mice , 2020, Stem Cell Research & Therapy.

[7]  R. Bhogal,et al.  The Delivery of Multipotent Adult Progenitor Cells to Extended Criteria Human Donor Livers Using Normothermic Machine Perfusion , 2020, Frontiers in Immunology.

[8]  I. Martin,et al.  Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature. , 2019, Cytotherapy.

[9]  P. Newsome,et al.  A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells , 2019, Front. Immunol..

[10]  H. Volk,et al.  Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines. , 2019, Trends in molecular medicine.

[11]  C. Connon,et al.  Alginate encapsulated multipotent adult progenitor cells promote corneal stromal cell activation via release of soluble factors , 2018, PloS one.

[12]  Giles T S Kirby,et al.  Development of Advanced Dressings for the Delivery of Progenitor Cells. , 2017, ACS applied materials & interfaces.

[13]  C. Mathieu,et al.  Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes , 2016, Diabetologia.

[14]  K. English,et al.  Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  Xiaobing Fu,et al.  Paracrine action of mesenchymal stromal cells delivered by microspheres contributes to cutaneous wound healing and prevents scar formation in mice. , 2015, Cytotherapy.

[16]  James A. Hutchinson,et al.  First‐in‐Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation , 2015, Stem cells translational medicine.

[17]  Giles T S Kirby,et al.  Stem Cells for Cutaneous Wound Healing , 2015, BioMed research international.

[18]  K. Shakesheff,et al.  The effect of injection using narrow‐bore needles on mammalian cells: administration and formulation considerations for cell therapies , 2015, The Journal of pharmacy and pharmacology.

[19]  B. Yao,et al.  Mesenchymal stromal cells enhance wound healing by ameliorating impaired metabolism in diabetic mice. , 2014, Cytotherapy.

[20]  P. Wilmarth,et al.  Dissection of the Human Multipotent Adult Progenitor Cell Secretome by Proteomic Analysis , 2013, Stem cells translational medicine.

[21]  C. Verfaillie,et al.  Human Multipotent Adult Progenitor Cells Are Nonimmunogenic and Exert Potent Immunomodulatory Effects on Alloreactive T-Cell Responses , 2013, Cell transplantation.

[22]  A. Cowin,et al.  Pericytes, Mesenchymal Stem Cells and the Wound Healing Process , 2013, Cells.

[23]  N. Salama,et al.  Effect of bone marrow derived mesenchymal stem cells on healing of induced full-thickness skin wounds in albino rat. , 2013, International journal of stem cells.

[24]  A. Skowera,et al.  Clinical-Grade Multipotent Adult Progenitor Cells Durably Control Pathogenic T Cell Responses in Human Models of Transplantation and Autoimmunity , 2013, The Journal of Immunology.

[25]  Louise E. Smith,et al.  A chemically defined carrier for the delivery of human mesenchymal stem/stromal cells to skin wounds. , 2012, Tissue engineering. Part C, Methods.

[26]  A. Luttun,et al.  Differentiation Potential of Human Postnatal Mesenchymal Stem Cells, Mesoangioblasts, and Multipotent Adult Progenitor Cells Reflected in Their Transcriptome and Partially Influenced by the Culture Conditions , 2011, Stem cells.

[27]  R. Weisel,et al.  Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair , 2010, Circulation.

[28]  N. Dash,et al.  Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. , 2009, Rejuvenation research.

[29]  J. Tolar,et al.  Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. , 2009, Blood.

[30]  J. Xiong,et al.  Rat marrow‐derived multipotent adult progenitor cells differentiate into skin epidermal cells in vivo , 2009, The Journal of dermatology.

[31]  A. Rivera,et al.  Promotion of incisional wound repair by human mesenchymal stem cell transplantation , 2009, Experimental dermatology.

[32]  Nerrolyn Ramstrand,et al.  Incidence of Lower-Limb Amputation in the Diabetic and Nondiabetic General Population , 2009, Diabetes Care.

[33]  A. Luttun,et al.  Multipotent adult progenitor cells sustain function of ischemic limbs in mice. , 2008, The Journal of clinical investigation.

[34]  A. Luttun,et al.  Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction , 2007, Journal of tissue engineering and regenerative medicine.

[35]  V. Falanga,et al.  Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. , 2007, Tissue engineering.

[36]  O. Velazquez,et al.  Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing. , 2007, Journal of vascular surgery.

[37]  Jingwu Z. Zhang,et al.  Yin and yang interplay of IFN-γ in inflammation and autoimmune disease , 2007 .

[38]  M. Kay,et al.  Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells. , 2006, Blood.

[39]  T. Nakatsuka,et al.  Bone marrow-impregnated collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical experience. , 2005, British journal of plastic surgery.

[40]  S. Bossi,et al.  Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries. , 2004, Transplantation proceedings.

[41]  O. Ringdén,et al.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.

[42]  M. Horan,et al.  Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. , 2003, The Journal of clinical investigation.

[43]  V. Falanga,et al.  Treatment of chronic wounds with bone marrow-derived cells. , 2003, Archives of dermatology.

[44]  G. Ashcroft,et al.  Androgen receptor-mediated inhibition of cutaneous wound healing. , 2002, The Journal of clinical investigation.

[45]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2002, Nature.

[46]  D. Patrick,et al.  A comparison of diabetic foot ulcer patients managed in VHA and non-VHA settings. , 2001, Journal of rehabilitation research and development.

[47]  OUP accepted manuscript , 2022, Stem Cells Translational Medicine.

[48]  G. Ashcroft,et al.  Tumor necrosis factor‐alpha (TNF‐α) is a therapeutic target for impaired cutaneous wound healing , 2012, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[49]  A. Maitra,et al.  Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell. , 2009, Journal of stem cells.

[50]  R. Short,et al.  Plasma-polymerized surfaces for culture of human keratinocytes and transfer of cells to an in vitro wound-bed model. , 2003, Journal of biomedical materials research. Part A.